Komori
Sobal (2186) · InitiativeUpdate to the number of outstanding stock acquisition rights

Stock options as share-based compensation for employees and others

First written in FY2020. 1 of 19 entries say "Restated". Latest entry: FY2027-H1.

19entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2020 – FY2027-H12020: 320202021: 420212022: 420222023: 320232024: 120242025: 220252026: 22026
Same theme, other companies
Grant and Issuance of Equity Compensation to Employees and Officers (Stock Options and Restricted Stock)A theme 654 companies write about · 0 as a headwind · 735 as a tailwind

18 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 179 companies compared. The sentences above are computed from all 179.Comparing 200 of the theme's 737 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 224 (Common shares: 22,400) Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 222 (Common shares: 22,200)」

    The number remaining under the fifth stock acquisition rights issue was updated from 224 rights covering 22,400 shares at the end of the previous fiscal year to 222 rights covering 22,200 shares.
  2. FY2026Update to the number of outstanding stock acquisition rightsAnnual report

    「Fifth stock acquisition rights issue: 224 (Common shares: 22,400)」

    The number of shares remaining subject to the fifth stock acquisition rights issue decreased from 226 rights covering 22,600 shares at the end of the previous fiscal year to 224 rights covering 22,400 shares. The exercise period runs from 1 June 2022 to 31 May 2032.
  3. FY2026-H1Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 224 (Common shares: 22,400)」

    The number remaining under the fifth stock acquisition rights issue was updated to 224 rights covering 22,400 common shares, down from 226 rights covering 22,600 shares at the end of the previous fiscal year. During the interim period, the company also recorded ¥128 thousand in reversal gains on stock acquisition rights.
  4. FY2025Update to the number of outstanding stock acquisition rightsAnnual report

    「Fifth stock acquisition rights issue: 226 (Common shares: 22,600)」

    The number remaining under the fifth stock acquisition rights issue was updated from 231 rights covering 23,100 shares at the end of the previous fiscal year to 226 rights covering 22,600 shares.
  5. FY2024Update to the number of outstanding stock acquisition rightsAnnual report

    「Fifth stock acquisition rights issue: 231 (Common shares: 23,100)」

    The number of shares remaining subject to the fifth stock acquisition rights issue decreased from 23,300 shares at the end of the previous fiscal year to 23,100 shares. The exercise period runs from 1 June 2022 to 31 May 2032.
  6. FY2024-Q2Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 235 (Common shares: 23,500) Fifth stock acquisition rights issue: 231 (Common shares: 23,100)」

    The number remaining under the fifth stock acquisition rights issue was updated from 235 rights covering 23,500 shares to 231 rights covering 23,100 shares.
  7. FY2024-Q1Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 266 (Common shares: 26,600) Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 231 (Common shares: 23,100)」

    The number remaining under the fifth stock acquisition rights issue was updated from 266 rights covering 26,600 shares at the end of the previous consolidated fiscal year to 231 rights covering 23,100 shares.
  8. FY2023Update to the number of outstanding stock acquisition rightsAnnual report

    「Fifth stock acquisition rights issue: 233 (Common shares: 23,300) / Exercise period: 1 June 2022 to 31 May 2032」

    The number remaining under the fifth stock acquisition rights issue was updated to 233 rights covering 23,300 shares, a decrease of 3,300 shares from the 26,600 shares outstanding at the end of the previous fiscal year.
  9. FY2023-Q2Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 / Fifth stock acquisition rights issue: 272 (Common shares: 27,200) / Fifth stock acquisition rights issue: 235 (Common shares: 23,500)」

    For the fifth stock acquisition rights issue, the number remaining was updated from 272 rights covering 27,200 shares at the end of the previous consolidated fiscal year to 235 rights covering 23,500 shares.
  10. FY2023-Q1Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 274 (Common shares: 27,400) Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 266 (Common shares: 26,600)」

    The number remaining under the fifth stock acquisition rights issue was updated from 274 rights covering 27,400 shares to 266 rights covering 26,600 shares.
  11. FY2022Update to the number of outstanding stock acquisition rightsAnnual report

    「Company employees: 116 / Subsidiary employees: 9 / Common shares: 26,600 / Exercise period: 1 June 2022 to 31 May 2032」

    For the fifth stock acquisition rights issue, the number of eligible recipients was updated to 116 company employees and 9 subsidiary employees, and the number of shares remaining subject to the rights to 26,600. This represents a forfeiture of 1,200 shares from the 27,800 shares outstanding at the end of the previous fiscal year.
  12. FY2022-Q3Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 270 (Common shares: 27,000)」

    The disclosure for the fifth stock acquisition rights issue was updated from 280 rights covering 28,000 common shares to 270 rights covering 27,000 shares. This filing does not state the reason for the decrease.
  13. FY2022-Q2Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 / Fifth stock acquisition rights issue: 285 (Common shares: 28,500) / Fifth stock acquisition rights issue: 272 (Common shares: 27,200)」

    For the fifth stock acquisition rights issue, the reported number remaining was updated from 285 rights covering 28,500 shares to 272 rights covering 27,200 shares.
  14. FY2022-Q1Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 293 (Common shares: 29,300) Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 274 (Common shares: 27,400)」

    The number remaining under the fifth stock acquisition rights issue was updated from 293 rights covering 29,300 shares in the same period of the previous year to 274 rights covering 27,400 shares.
  15. FY2021Update to the number of outstanding stock acquisition rightsAnnual report

    「The information is as of the end of the consolidated fiscal year. Matters changed between the final day of the consolidated fiscal year and 30 April 2021, the end of the month preceding the month in which the annual securities report was filed, are shown in brackets as of the end of the month preceding the filing date. / Common shares: 27,800 [27,600]」

    The fifth stock option issue had 27,800 shares outstanding at the end of the fiscal year and 27,600 shares at the end of April 2021, reflecting the updated number remaining after forfeitures and other changes following the grant. The exercise period runs from 1 June 2022 to 31 May 2032.
  16. FY2021-Q3Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 280 (Common shares: 28,000)」

    The disclosure for the fifth stock acquisition rights issue was updated to 280 rights covering 28,000 common shares. The number decreased by 5 rights and 500 shares from the previously reported 285 rights and 28,500 shares, but this filing does not state the reason.
  17. FY2021-Q2Update to the number of outstanding stock acquisition rightsAnnual report

    「Stock acquisition rights approved by the Board of Directors on 9 March 2020 Fifth stock acquisition rights issue: 285 (Common shares: 28,500)」

    The disclosure was updated to show 285 stock acquisition rights covering 28,500 common shares under the fifth stock acquisition rights issue. The number changed from the previously reported 295 rights and 29,500 shares, but this filing does not state the reason for the change.
  18. FY2021-Q1RestatedAnnual report

    「Company employees 130 Subsidiary employees 9 Number of stock acquisition rights ※ 295 Class, description and number of shares underlying the stock acquisition rights ※ Common shares 29,500」

    The disclosure reiterates the number of eligible recipients and the grant of 295 stock acquisition rights covering 29,500 shares under the fifth stock acquisition rights issue, with an exercise period from 1 June 2022 to 31 May 2032.
  19. FY2020First statedAnnual report

    「The company will issue stock options as share-based compensation (stock acquisition rights) to its employees and others, with the aim of sharing with shareholders the benefits and risks of share-price movements and providing greater incentives than before to improve long-term business performance and corporate value.」

    The disclosure describes the allocation of a total of 295 stock acquisition rights, covering 29,500 shares, to 130 company employees and 9 subsidiary employees. The exercise period runs from 1 June 2022 to 31 May 2032.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sobal yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Stock options as share-based compensation for employees and others | Sobal Corporation (2186) | Komori